(R)-GNE-140
CAS: 2003234-63-5
Ref. 3D-DFD23463
| 1mg | 76.00 € | ||
| 2mg | 104.00 € | ||
| 5mg | 166.00 € | ||
| 10mg | 234.00 € | ||
| 25mg | 352.00 € |
Product Information
(R)-GNE-140 is a potential cancer treatment that inhibits the metabolic reprogramming of cancer cells. It has been shown to inhibit the aerobic glycolysis of cancer cells and induce anaerobic glycolysis, which is less efficient in generating ATP. This drug inhibits the activity of the enzyme aldolase A, which converts glyceraldehyde-3-phosphate into dihydroxyacetone phosphate. This inhibition leads to decreased ATP production and increased lactate production, providing a possible therapeutic strategy for treating cancers.
Chemical properties
Technical inquiry about: 3D-DFD23463 (R)-GNE-140
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
